Skip to main content

Advertisement

SpringerLink
Log in

Mast Cells

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Mast cells have been considered for many years to participate specifically in allergic reactions through the release of cytokines, chemokines, proteases, leukotrienes, and bioactive polyamines. Emerging roles for mast cells have been identified recently, which highlight their relevance in both innate and adaptive immunity. Mast cells play a role in many different processes, including clearance of enteric pathogens, food allergies, visceral hypersensitivity, and intestinal cancer. The activation of mast cells can initiate inflammatory reactions that are life-saving in some circumstances (eg, nematode infection) but life-threatening in others (eg, allergy). In recent years, mast cells, their products, and the mechanisms by which mast cell activity can be regulated by the microenvironment are a major area of investigation. The purpose of this review article is to summarize and highlight the latest findings in mast cell biology associated with intestinal homeostasis and pathologies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Heib V, Becker M, Taube C, Stassen M: Advances in the understanding of mast cell function. Br J Haematol 2008, 142:683–694. This excellent review article highlights recent advances in human and murine mast cell function, focusing on their role in innate and adaptive immunity. It also includes information on mast cell subsets, and describes pertinent tools in mast cell research, including animal models.

    Article  CAS  PubMed  Google Scholar 

  2. Stone KD, Prussin C, Metcalfe DD: IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 2010, 125:S73–S80.

    Article  PubMed  Google Scholar 

  3. Alcaide P, Jones TG, Lord GM, et al.: Dendritic cell expression of the transcription factor T-bet regulates mast cell progenitor homing to mucosal tissue. J Exp Med 2007, 204:431–439.

    Article  CAS  PubMed  Google Scholar 

  4. Bischoff SC, Lorentz A, Schwengberg S, et al.: Mast cells are an important cellular source of tumour necrosis factor-α in human intestinal tissue. Gut 1999, 44:643–652.

    Article  CAS  PubMed  Google Scholar 

  5. Vosskuhl K, Greten TF, Manns MP, et al.: Lipopolysaccharide-mediated mast cell activation induces IFN-gamma secretion by NK cells. J Immunol 2010, 185:119–125.

    Article  CAS  PubMed  Google Scholar 

  6. Jordan WJ, Eskdale J, Srinivas S, et al.: Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. Genes Immun 2007, 8:254–261.

    Article  CAS  PubMed  Google Scholar 

  7. He S, Zhang H, Chen H, Yang H, et al.: Expression and release of IL-29 by mast cells and modulation of mast cell behavior by IL-29. Allergy 2010 (Epub ahead of print).

  8. Rook GA: Review series on helminths, immune modulation and the hygiene hypothesis: the broader implications of the hygiene hypothesis. Immunology 2009, 126:3–11.

    Article  CAS  PubMed  Google Scholar 

  9. Blum LK, Thrasher SM, Gagliardo LF, et al.: Expulsion of secondary Trichinella spiralis infection in rats occurs independently of mucosal mast cell release of mast cell protease II. J Immunol 2009, 183:5816–5822.

    Article  CAS  PubMed  Google Scholar 

  10. Dardalhon V, Awasthi A, Kwon H, et al.: IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008, 9:1347–1355.

    Article  CAS  PubMed  Google Scholar 

  11. Elyaman W, Bradshaw EM, Uyttenhove C, et al.: IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci U S A 2009, 106:12885–12890.

    Article  CAS  PubMed  Google Scholar 

  12. Angkasekwinai P, Park H, Wang YH, et al.: Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007, 204:1509–1517.

    Article  CAS  PubMed  Google Scholar 

  13. • Ierna MX, Scales HE, Saunders KL, Lawrence CE: Mast cell production of IL-4 and TNF may be required for protective and pathological responses in gastrointestinal helminth infection. Mucosal Immunol 2008, 1:147–155. In this study, the authors demonstrated, with elegant reconstitution experiments, the impaired clearance of the enteric helminth Trichinella spiralis observed in mast cell-deficient mice is associated with a lack of mast cell release of TNF-a and IL-4. Further, in the same study the authors define the importance of the same mast cell-derived mediators in the development and degree of parasite-associated enteropathy.

    Article  CAS  PubMed  Google Scholar 

  14. Schmitz J, Owyang A, Oldham E, et al.: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479–490.

    Article  CAS  PubMed  Google Scholar 

  15. Castellani ML, Kempuraj D, Salini V, et al.: The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator. J Biol Regul Homeost Agents 2009, 23:11–14.

    CAS  PubMed  Google Scholar 

  16. Liew FY, Pitman NI, McInnes IB: Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010, 10:103–110.

    Article  CAS  PubMed  Google Scholar 

  17. Xu D, Jiang HR, Kewin P, et al.: IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A 2008, 105:10913–10918.

    Article  CAS  PubMed  Google Scholar 

  18. •• Humphreys NE, Xu D, Hepworth MR, et al.: IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol 2008, 180:2443–2449. In this experimental article the authors describe, for the first time, the roles of IL-33 as a potent inducer of adaptive immunity to Trichuris muris, an enteric nematode belonging to the same clade as T. spiralis. The authors show that IL-33 is highly expressed during early phases of parasite infection. Furthermore, it is demonstrated that exogenous administration of IL-33 is sufficient to induce helminth expulsion, and that infection-related pathologic changes are independent of adaptive immunity.

    CAS  PubMed  Google Scholar 

  19. Castells MC, Klickstein LB, Hassani K, et al.: gp49B1-alpha(v)beta3 interaction inhibits antigen-induced mast cell activation. Nat Immunol 2001, 2:436–442.

    CAS  PubMed  Google Scholar 

  20. • Kataoka TR, Kumanogoh A, Bandara G, et al.: CD72 negatively regulates KIT-mediated responses in human mast cells. J Immunol 2010, 184:2468–2475. Inhibition/attenuation of mast cell activation is an emerging area. In this study, the authors show that the ITIM-containing receptor CD72 can downregulate c-KIT–mediated functions, including proliferation and protease production.

    Article  CAS  PubMed  Google Scholar 

  21. • Hitomi K, Tahara-Hanaoka S, Someya S, et al.: An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions. Nat Immunol 2010, 11:601–607. The regulation of mast cells in hypersensitivity reactions takes a major step forward with the identification of Allergin-1, which contains an ITIM domain and coligates with FcεRI to inhibit IGE-mediated, mast cell-dependent anaphylaxis.

    Article  CAS  PubMed  Google Scholar 

  22. • Trivedi NN, Caughey GH: Mast cell peptidases: chameleons of innate immunity and host defense. Am J Respir Cell Mol Biol 2010, 42:257–267. This article is a timely review on the clinical importance of mast cell proteases and includes an historical time line of milestones in the research of chymase and tryptase.

    Article  CAS  PubMed  Google Scholar 

  23. Crivellato E, Ribatti D: The mast cell: an evolutionary perspective. Biol Rev Camb Philos Soc 2010, 85:347–360.

    Article  PubMed  Google Scholar 

  24. • Reimer J, Samollow P, Hellman L: High degree of conservation of the multigene tryptase locus over the past 150–200 million years of mammalian evolution. Immunogenetics 2010, 62:369–382. This original paper presents an analysis of the multigene tryptase locus across several species to better understand the conservation of mast cell proteases during the course of evolution.

    Article  CAS  PubMed  Google Scholar 

  25. Caughey GH: Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 2007, 217:141–154.

    Article  CAS  PubMed  Google Scholar 

  26. Coughlin SR, Camerer E: Participation in inflammation. J Clin Invest 2003, 111:25–27.

    CAS  PubMed  Google Scholar 

  27. Madden KB, Yeung KA, Zhao A, et al.: Enteric nematodes induce stereotypic STAT6-dependent alterations in intestinal epithelial cell function. J Immunol 2004, 172:5616–5621.

    CAS  PubMed  Google Scholar 

  28. Miller HR, Pemberton AD: Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 2002, 105:375–390.

    Article  CAS  PubMed  Google Scholar 

  29. •• Groschwitz KR, Ahrens R, Osterfeld H, et al.: Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism. Proc Natl Acad Sci U S A 2009, 106:22381–22386. This study shows a novel role for a mast cell product Mcpt4, which regulates intestinal barrier homeostasis and function. In Mcpt4-deficient mice, impaired intestinal barrier function was the result of altered migration of cells along the crypt to villus axis, altered morphology, and dysregulated claudin 3 expression.

    Article  CAS  PubMed  Google Scholar 

  30. McDermott JR, Bartram RE, Knight PA, et al.: Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci U S A 2003, 100:7761–7766.

    Article  CAS  PubMed  Google Scholar 

  31. Jacob C, Yang PC, Darmoul D, et al.: Mast cell tryptase controls paracellular permeability of the intestine: role of protease-activated receptor 2 and beta-arrestins. J Biol Chem 2005, 280:31936–31948.

    Article  CAS  PubMed  Google Scholar 

  32. Sutton TL, Zhao A, Madden KB, et al.: Anti-inflammatory mechanisms of enteric Heligmosomoides polygyrus infection against trinitrobenzene sulfonic acid-induced colitis in a murine model. Infect Immun 2008, 76:4772–4782.

    Article  CAS  PubMed  Google Scholar 

  33. Bischoff S: Physiological and pathophysiological functions of intestinal mast cells. Semin Immunopathol 2009, 31:185–205.

    Article  CAS  PubMed  Google Scholar 

  34. Ito A, Hagiyama M, Oonuma J: Nerve-mast cell and smooth muscle-mast cell interaction mediated by cell adhesion molecule-1, CADM1. J Smooth Muscle Res 2008, 44:83–93.

    Article  PubMed  Google Scholar 

  35. • Suekane T, Ikura Y, Watanabe K, et al.: Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: relevance to local angiotensin II system. J Gastroenterol 2010 (Epub ahead of print). This article reviews the recent studies showing that CADM1, a member of the immunoglobulin superfamily and expressed by a variety of cells, mediates the interactions between nerve-mast cell and smooth muscle-mast cell.

  36. •• Spiller R, Garsed K: Postinfectious irritable bowel syndrome. Gastroenterology 2009, 136:1979–1988. This article is one of several recent reviews on this topic that provides a very thorough discussion of the current knowledge and opinion on epidemiology, clinical presentation, mechanisms, differential diagnosis, and management. This report also provides additional resources, including a list of publications and pertinent details on the incidence of postinfectious IBS.

    Article  PubMed  Google Scholar 

  37. Barbara G, Wang B, Stanghellini V, et al.: Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007, 132:26–37.

    Article  CAS  PubMed  Google Scholar 

  38. Cremon C, Gargano L, Morselli-Labate AM, et al.: Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009, 104:392–400.

    Article  CAS  PubMed  Google Scholar 

  39. • Winston JH, Xu GY, Sarna SK: Adrenergic stimulation mediates visceral hypersensitivity to colorectal distension following heterotypic chronic stress. Gastroenterology 2010, 138:294–304. This study demonstrated that chronic stress-induced visceral hypersensitivity in rats is mediated by adrenergic-stimulated release of norepinephrine, resulting in increased expression of nerve growth factor, which in turn sensitizes the visceral afferent neurons.

    Article  CAS  PubMed  Google Scholar 

  40. Barbara G, Cremon C, Pallotti F, et al.: Postinfectious irritable bowel syndrome. J Pediatr Gastroenterol Nutr 2009, 48(Suppl 2):S95–S97.

    Article  CAS  PubMed  Google Scholar 

  41. Ohman L, Simren M: Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010, 7:163–173.

    Article  PubMed  Google Scholar 

  42. Lee KJ, Kim YB, Kim JH, et al.: The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 2008, 23:1689–1694.

    Article  PubMed  Google Scholar 

  43. • Kim HS, Lim JH, Park H, Lee SI: Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection—an observation in a small case control study. Yonsei Med J 2010, 51:45–51. Although reporting on a very small sample, this article provides unique information about long-term changes in mucosal immunology in postinfectious IBS.

    Article  PubMed  Google Scholar 

  44. Guilarte M, Santos J, de Torres I, et al.: Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007, 56:203–209.

    Article  PubMed  Google Scholar 

  45. Walker MM, Talley NJ, Prabhakar M, et al.: Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2009, 29:765–773.

    Article  CAS  PubMed  Google Scholar 

  46. Yu LC-H: The epithelial gatekeeper against food allergy. Pediatr Neonatol 2009, 50:247–254.

    Article  PubMed  Google Scholar 

  47. Traver E, Torres R, de Mora F, Vergara P: Mucosal mast cells mediate motor response induced by chronic oral exposure to ovalbumin in the rat gastrointestinal tract. Neurogastroenterol Motil 2010, 22:e34–e43.

    CAS  PubMed  Google Scholar 

  48. Kurashima Y, Kunisawa J, Higuchi M, et al.: Sphingosine 1-phosphate-mediated trafficking of pathogenic Th2 and mast cells for the control of food allergy. J Immunol 2007, 179:1577–1585.

    CAS  PubMed  Google Scholar 

  49. •• Forbes EE, Groschwitz K, Abonia JP, et al.: IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med 2008, 205:897–913. This study identified an important role for IL-9 in oral antigen hypersensitivity. IL-9–deficient mice do not develop intestinal anaphylaxis in response to oral antigen, whereas overexpression of IL-9 in the intestine leads to an anaphylaxis phenotype with intestinal mastocytosis, intestinal permeability, and intravascular leakage. The intestinal response to IL-9 requires mast cells, further supporting the contribution of IL-9 to mast-cell responses during food allergy.

    Article  CAS  PubMed  Google Scholar 

  50. Osterfeld H, Ahrens R, Strait R, et al.: Differential roles for the IL-9/IL-9 receptor [alpha]-chain pathway in systemic and oral antigen-induced anaphylaxis. J Allergy Clin Immunol 2010, 125:469–476.

    Article  CAS  PubMed  Google Scholar 

  51. Gounaris E, Erdman SE, Restaino C, et al.: Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A 2007, 104:19977–19982.

    Article  CAS  PubMed  Google Scholar 

  52. •• Gounaris E, Blatner NR, Dennis K, et al.: Cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res 2009, 69:5490–5497. Previous reports indicated that Tregs reduced cancer-associated inflammation and therefore provide protection. Using a murine model of hereditary colon cancer, the authors showed that Tregs begin to produce IL-17, which causes inflammation. Although non-IL-17–producing Tregs were found to reduce focal mastocytosis, these altered IL-17–producing Tregs promoted focal mastocytosis. This step is critical to the tumor-promoting inflammatory response in colon cancer.

    Article  CAS  PubMed  Google Scholar 

  53. Blatner NR, Bonertz A, Beckhove P, et al.: In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction. Proc Natl Acad Sci U S A 2010, 107:6430–6435.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Dr. Terez Shea-Donohue, Dr. Aiping Zhao, and Dr. Luigi Notari are supported by National Institutes of Health RO1 grants. The authors acknowledge the support of RO1 AI49316, which was awarded to Dr. Shea-Donohue. Ms. Jennifer Stiltz is supported by a T32 training grant.

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

  1. Department of Medicine and Mucosal Biology Research Center, University of Maryland School of Medicine, 20 Penn Street, Baltimore, MD, 21201, USA

    Terez Shea-Donohue, Jennifer Stiltz, Aiping Zhao & Luigi Notari

Authors
  1. Terez Shea-Donohue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Stiltz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aiping Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luigi Notari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Terez Shea-Donohue.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shea-Donohue, T., Stiltz, J., Zhao, A. et al. Mast Cells. Curr Gastroenterol Rep 12, 349–357 (2010). https://doi.org/10.1007/s11894-010-0132-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-010-0132-1

Keywords

Search

Navigation